This company has been marked as potentially delisted and may not be actively trading. Acer Therapeutics (ACER) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ACER Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Asphyxia Market Expected to rise, 2032 | Pharmazz, Inc., ReAlta Life Sciences, Acer Therapeutics, expected to drive marketMarch 4, 2025 | theglobeandmail.comZevra sells priority review voucher for $150m to support drug launchesFebruary 27, 2025 | finance.yahoo.comGoogle Cloud to mandate Multi-Factor Authentication from 2025- ReportNovember 6, 2024 | msn.comVascular Ehlers-Danlos Syndrome Market on Track for Major Expansion by 2032, According to DelveInsight | Aytu BioPharma, Acer TherapeuticsNovember 5, 2024 | theglobeandmail.comGlobal and Taiwan ICT Industry Research Report 2024: Market Performance, AI PC and AI Server Shipment Forecasts 2020-2024 & 2024-2028November 4, 2024 | finance.yahoo.comAcer Therapeutics Inc (OTC:ACER) Stock Quotes, Forecast and News SummaryAugust 16, 2024 | benzinga.comAnumana Appoints Harry S. Palmin as CFOMay 14, 2024 | tmcnet.comVehicle crashes into North Avenue restaurantMay 1, 2024 | msn.comArrest made following shots fired incident on Vann AvenueApril 30, 2024 | msn.comZevra Therapeutics' President and Chief Executive Officer Issues Letter to Stockholders Highlighting Recent Key Accomplishments and Outlook for 2024April 29, 2024 | finanznachrichten.de2 hospitalized after double shooting on Hudson Avenue in RochesterApril 28, 2024 | msn.comFBI was on scene of incident in Portsmouth on Broomhill AvenueApril 27, 2024 | msn.comCrews responding to structure fire on Spruill AvenueApril 26, 2024 | msn.comFBI was scene of incident in Portsmouth on Broomhill AvenueApril 26, 2024 | msn.comKohr Explores: 82nd Avenue of Roses Parade takes to the streets SaturdayApril 26, 2024 | msn.comNorth Avenue closureApril 26, 2024 | msn.comFire crews on the scene of Denby Avenue structure fireApril 26, 2024 | msn.comMan killed in hit-and-run on Jackson AvenueApril 25, 2024 | msn.comZevra Therapeutics Inc (ZVRA) Earnings: A Mixed Bag Against Analyst Estimates with Significant ...March 28, 2024 | uk.finance.yahoo.comHow to score 50% off The Legend of Zelda: Breath of the WildFebruary 22, 2024 | msn.comAcer Therapeutics Inc Stock (OTC:ACER), Guidance and ForecastJanuary 6, 2024 | benzinga.comAcer Therapeutics Inc Stock (OTC:ACER) Dividends: History, Yield and DatesJanuary 6, 2024 | benzinga.comZevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical OfficerJanuary 4, 2024 | finance.yahoo.comRelief Therapeutics Holding SA RLFDecember 31, 2023 | morningstar.comAcer Therapeutics Stock (NASDAQ:ACER) Insider TradesNovember 18, 2023 | benzinga.comZevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial ResultsNovember 7, 2023 | markets.businessinsider.comZevra Therapeutics Inc (ZVRA) Reports Q3 2023 Financial ResultsNovember 7, 2023 | finance.yahoo.comLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related ProposalsNovember 2, 2023 | finance.yahoo.comAcer Therapeutics Inc. (ACER)November 1, 2023 | sg.finance.yahoo.comHC Wainwright Downgrades Acer TherapeuticsSeptember 6, 2023 | 247wallst.comRoth MKM Downgrades Acer TherapeuticsSeptember 5, 2023 | 247wallst.comZevra's Rare Find: Unearthing Value In Niche Rare Diseases The Market OverlooksSeptember 5, 2023 | msn.comRoth Capital Downgrades Acer Therapeutics (ACER)September 2, 2023 | msn.comRoth MKM Downgrades Acer Therapeutics (ACER)September 2, 2023 | msn.comAcer (ACER) to Get Acquired by Zevra for $91M, Stock UpSeptember 1, 2023 | msn.comAcer Therapeutics will reacquire OLPRUVA rights from Relief TherapeuticsSeptember 1, 2023 | msn.comZevra Therapeutics to Buy Acer Therapeutics >ZVRA ACERAugust 31, 2023 | marketwatch.comUS Stocks Rise; Initial Jobless Claims Edge LowerAugust 31, 2023 | markets.businessinsider.comWhy Is Acer Therapeutics Stock Trading Higher Today?August 31, 2023 | msn.comACER Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Acer Therapeutics Inc. Is Fair to ShareholdersAugust 31, 2023 | technews.tmcnet.comAcer Therapeutics Shares Take Flight on Zevra DealAugust 31, 2023 | marketwatch.comAcer Therapeutics surges as Zevra agrees to acquire for up to $91MAugust 31, 2023 | seekingalpha.comZerva acquires Acer Therapeutics to bolster rare disease portfolioAugust 31, 2023 | msn.comAcer Therapeutics (NASDAQ:ACER) Skyrockets on Acquisition by Zevra TherapeuticsAugust 31, 2023 | msn.comZevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial ProductAugust 31, 2023 | finance.yahoo.comStruggling Newton biotech Acer Therapeutics scooped up by Florida firmAugust 31, 2023 | finance.yahoo.comTrading was temporarily halted for "ACER" at 09:08 AM with a stated reason of "LULD pause."August 31, 2023 | marketbeat.comTrading was temporarily halted for "ACER" at 09:08 AM with a stated reason of "LULD pause."August 31, 2023 | marketbeat.comRelief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA (ACER-001) with Acer TherapeuticsAugust 30, 2023 | markets.businessinsider.comAcer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical EuropeAugust 30, 2023 | finance.yahoo.com Get Acer Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter. Email Address ACER Media Mentions By Week ACER Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACER News Sentiment▼-0.351.03▲Average Medical News Sentiment ACER News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACER Articles This Week▼00▲ACER Articles Average Week Get Acer Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Applied Therapeutics News Exicure News Skye Bioscience News Citius Oncology News Context Therapeutics News PyroGenesis Canada News Adicet Bio News Immix Biopharma News Repare Therapeutics News Verrica Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACER) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredDollar Collapse Warning: Protect Your Wealth NOWGlobal central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acer Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acer Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACER Stock Free ACER Stock Alerts